t-channels

1-Octanol (Octanol) 是一种饱和脂肪醇，是一种 T 型钙通道抑制剂，对天然 T 电流的IC50为 4 μM。它是一种具有类似柴油特性的极具吸引力的生物燃料。

RQ00203078是一种口服有效的TRPM8高选择性拮抗剂，对大鼠和人类TRPM8通道的IC50分别为 5.3 nM 和 8.3 nM。它对 TRPV1，TRPA1，TRPV4 或 TRPM2 通道基本没有抑制作用。

Zonisamide (AD 810) 是锌酶碳酸酐酶 (carbonic anhydrase) 的有效抑制剂，对人类线粒体同工酶 hCA II 和 hCA V 作用的 Ki 值分别为 35.2 nM 和 20.6 nM。Zonisamide 具有抗癫痫活性，在癫痫、癫痫发作和帕金森病的研究中具有价值。

Trimethadione (3,5,5,-Trimethyloxazolidine-2,4-dione) 是恶唑烷二酮类抗惊厥剂，也是一种 T 型钙通道阻滞剂，具有抗痛觉过敏作用，可用于研究失神发作。

Lomerizine dihydrochloride (KB-2796) 是双重 L 和 T 型电压门控钙通道拮抗剂。

Atagabalin, also known as PD 0200390, is a gabamimetic agent under development for the treatment for insomnia. Atagabalin is related to gabapentin, which similarly binds to the α2δ calcium channels (1 and 2). It was discontinued following unsatisfactory t

UK 78282 hydrochloride，一种新型有效且具有选择性的 Kv1.3 阻滞剂。UK 78282 hydrochloride 抑制 Kv1.3 电压门控钾通道，抑制人 T 细胞活化。

Mibefradil dihydrochloride (Ro 40-5967 (dihydrochloride)) 是一种钙离子通道抑制剂，选择性作用于 T 型 Ca2+通道，对 T 型和 L 型通道的IC50分别为 2.7 和 18.6 μM。

ML218 hydrochloride is a selective and orally active T-type Ca2+ channels (Cav3.1, Cav3.2, Cav3.3) inhibitor (Cav3.2 and Cav3.3 with IC50s of 310 nM and 270 nM , respectively).

ML218 是一种具有口服活性、选择性、高效性且可穿透血脑屏障的 T 型 Ca2+ 通道抑制剂（Cav3.2 和 Cav3.3 的 IC50 分别为 310 nM 和 270 nM）。ML218 可抑制丘脑下核（STN）神经元的突发性活动。

T16Ainh-A01 是氨基苯基噻唑，是有效的跨膜蛋白 16A 的抑制剂，抑制 TMEM16A 介导的氯离子电流，IC50约为1 µM。TMEM16A (ANO1)起钙激活氯离子通道(CaCC)的作用。

ICILIN (AG-3-5) 是一种有效的的瞬时受体电位 M8 (TRPM8) 离子通道激动剂。 Icilin 激活 EGTA 中的 TRPM8，该激活作用具有剂量依赖性， EC50=1.4 μM。Icilin 通过调节 T 细胞反应减轻自身免疫性神经炎症。

HM12 是一种针对 L 型/T 型钙通道 (L-/T-type calcium channel) 的共价抑制剂。它能够强效抑制 Cav1.2 (L 型) 和 Cav3.2 (T 型) 钙通道，并对 N 型通道表现出选择性。HM12 的抑制作用不可逆，即使在洗脱后效果仍持续存在。该化合物可用于高血压、疼痛、癫痫等疾病的研究。

Efonidipine (NZ-105) 是一种二氢吡啶类钙通道阻滞剂，可阻断 T 型和 L 型钙通道。

NMP-7 is a non-selective CB1 and CB2 cannabinoid receptor agonist that works by blocking T-type calcium channels.

Z944 是有效的 T 型钙通道拮抗剂，对跨模态和视觉识别记忆障碍有缓解作用。

N-Arachidonoyl taurine is an arachidonoyl amino acid. It is oxygenated by 12(S)- and 15(S)-lipoxygenase and is converted to 12-HETE-taurine (12-HETE-T) in murine resident peritoneal macrophages. N-Arachidonoyl taurine is an activator of the transient receptor potential vanilloid (TRPV) channels TRPV1 and TRPV4 (EC50s = 28 and 21 μM, respectively). It increases calcium flux in HIT-T15 pancreatic β-cells and INS-1 rat islet cells when used at a concentration of 10 μM and increases insulin secretion from 832/13 INS-1 pancreatic β-cells. The levels of N-arachidonoyl taurine are changed in mouse brain following administration of δ9-tetrahydrocannabinol (δ9-THC).

5(6)-EET is a fully racemic version of the enantiomeric forms biosynthesized from arachidonic acid by cytochrome P450 enzymes. In solution, 5(6)-EET degrades into 5,6-DiHET and 5(6)-δ-lactone, which can be converted to 5(6)-DiHET and quantified by GC-MS. In neuroendocrine cells, such as the anterior pituitary and pancreatic islets, 5(6)-EET has been implicated in the mobilization of calcium and hormone secretion. 5(6)-EET is an inhibitor of T-type voltage-gated calcium channels (Cav3) that inhibits isoforms Cav3.1, Cav3.2 (IC50 = 0.54 μM), and Cav3.3 and decreases nifedipine-resistant phenylephrine-induced vasoconstriction in isolated mouse mesenteric arteries via Cav3.2 blockade when used at a concentration of 3 μM. In addition, it is a substrate of COX-1 and COX-2, as measured by oxygen consumption and product formation assays when used at a concentration of 50 μM. (±)5(6)-EET is provided as a mixture of the free acid and lactone.

(2R/S)-6-PNG (6-Prenylnaringenin) 是新型天然组蛋白脱乙酰酶抑制剂，具有抗癌抗肿瘤活性，可阻断T型钙通道可减轻小鼠的神经性和内脏疼痛。

Zonisamide-13C2,15N is intended for use as an internal standard for the quantification of zonisamide by GC- or LC-MS. Zonisamide (T0267) is an antiepileptic agent.1 It selectively inhibits the repeated firing of sodium channels (IC50 = 2 μg/ml)in mouse embryo spinal cord neurons and inhibits spontaneous channel firing when used at concentrations greater than 10 μg/ml.2 In rat cerebral cortex neurons,zonisamide (1-1,000 μM)inhibits T-type calcium channels with a maximum reduction of 60% of the calcium current.3 Zonisamide (T0267)inhibits H. pylori recombinant carbonic anhydrase (CA)and the human CA isoforms I,II,and V with Ki values of 218,56,35,and 21 nM,respectively.4,5 In mice,it has anticonvulsant activity against maximal electroshock seizure (MES)and pentylenetetrazole-induced maximal,but not minimal,seizures (ED50s = 19.6,9.3,and >500 mg/kg,respectively). Zonisamide (T0267) (40 mg/kg,p.o.)prevents MPTP-induced decreases in the levels of dopamine ,but not homovanillic acid or dihydroxyphenyl acetic acid ,and increases MPTP-induced decreases in the dopamine turnover rate in mouse striatum in a model of Parkinson's disease.6 Formulations containing zonisamide have been used in the treatment of partial seizures in adults with epilepsy.

Suvecaltamide (MK-8998) 是一种选择性的 T 型钙通道抑制剂。

IAA65 是一种强效、高选择性的瞬时受体电位通道 A1 (TRPA1) 抑制剂 (IC50 = 4.3 nM)。它通过竞争性阻断感觉神经元中 TRPA1 介导的钙离子内流，在炎症性疼痛及神经病理性疼痛的动物模型中显示出显著的镇痛活性。

TTA-P1 is a highly potent compound that effectively inhibits human T-type calcium channels, which are involved in various physiological processes such as neuronal burst firing, hormone secretion, and cell growth. With its unique state-independent properties, TTA-P1 holds promising potential for advancing research on absence epilepsy [1].

TTA-P2 (T-Type calcium channel inhibitor) 是一种 T 型钙通道的有效抑制剂。TTA-P2 能够有效的穿透 CNS 并阻断小脑深部核神经元中的天然 T 型电流，完全消除野生型和突变型 Cav3.1 通道的窗口电流。TTA-P2 具有潜力进行神经疾病的研究。